Trial Profile
Rapid Evaluation of Lifestyle, Independence, and Elimination of Breakthrough Cancer Pain With Freedom From Oral Discomfort Through the Use of Abstral (Fentanyl) Sublingual Tablets
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2015
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Acronyms RELIEF
- Sponsors Galena Biopharma
- 04 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 May 2015 New trial record